Raupya Bhasma: Benefits, Evidence & Safety

TL;DR

Raupya Bhasma (Rajata Bhasma) is purified silver processed by repeated Ayurvedic incineration into an ash. Modern analysis shows crystalline silver nanoparticle aggregates (roughly 170–210 nm), not bulk metallic silver. Traditional texts use it as a rasayana for nervous and eye disorders. Lab studies report antimicrobial activity, but no human trials exist: and chronic excess silver can permanently discolour skin. (57 words. Sources: Rajath Bhasma characterisation study 2020; nano-silver systematic review.)

What it is

Raupya Bhasma (also called Rajata Bhasma or Chandi Bhasma) is a calcined silver preparation of Ayurveda's Rasa Shastra tradition: purified silver (Shuddha Rajata) is incinerated with sulphur and herbal juices through repeated heating cycles until it becomes a fine ash. A 2020 characterisation study using FTIR, SEM, XRD and particle sizing found that Rajath Bhasma consists mainly of crystalline silver, nanoparticle aggregates roughly 170–210 nm in size, with herb-derived organic surface groups (XRD also showed silver oxide/carbonate phases), a very different material from metallic silver or modern colloidal silver (Rajath Bhasma characterisation study, JAKO 2020). A systematic review of nano-silver in medicine describes Raupya/Rajat Bhasma as the ancient Ayurvedic form of nano-silver (Medwin systematic review).

Traditional use

Rasa Shastra texts describe Rajata Bhasma as a rasayana (rejuvenator) with cooling potency, traditionally used for nervous-system complaints (headache, vertigo, memory weakness), eye disorders, and as a general tonic. Classical practice also values it for calming Pitta and Vata (Ayurvedic practitioner reference); a peer-reviewed characterisation paper similarly records traditional use for memory loss and eye diseases (Kalimuthu et al., J Microbiol Biotechnol 2020). These are traditional claims: the modern evidence is assessed separately below.

What modern research says

Antimicrobial activity — in-vitro, with a toxicity threshold

The 2020 characterisation study tested Rajath Bhasma against microbes and in zebrafish embryos: it showed antimicrobial activity and no toxicity at low concentrations (below 5 μg/ml), while noting this was the first study of its kind and calling for more work (JAKO 2020). In-vitro antimicrobial activity does not mean it treats infections in people.

Interaction with human cells — in-vitro

A 2023 laboratory study exposed human cell lines to gold bhasma and silver parpam (a related calcined silver preparation): under the experimental conditions, neither preparation showed toxicity to the human cells, with particles taken up preferentially by cancer cells in the dish (Badilescu & Packirisamy, J Nat Ayurvedic Med 2023). Cell-dish findings are not clinical evidence.

Anti-cancer activity — in-vitro only

A 2022 synthesis-and-characterisation study reported that Rajat Bhasma killed MCF-7 human breast-cancer cells in the dish (IC₅₀ ≈ 78.5 μg/ml), describing it as a less toxic form of silver compound (Naikare et al., NeuroQuantology 2022). Killing cancer cells in a dish is the very first step of drug research: it is not evidence of a cancer treatment.

Silver absorption and mineral interactions — animal study

A chick study of ingested silver in bhasm, leaf (varak) and colloidal forms found significant silver accumulation in blood, liver, spleen and kidneys, along with a significant fall in blood copper: showing that ingested bhasma-form silver is systemically absorbed and can disturb essential-mineral balance (R. Sharma et al., Indian J Clin Biochem 2009).

The honest gap

No published human clinical trial of Raupya Bhasma for any condition could be found. The nano-silver systematic review concludes that more toxicity studies are needed before the safety and efficacy of these preparations can be considered established (Medwin systematic review).

Safety & contraindications

The specific silver risk is argyria: chronic excess silver exposure can cause permanent grey-blue discolouration of the skin, a limitation noted across the nano-silver literature (Medwin systematic review). The general bhasma risk is contamination: a JAMA study found that about one in five Ayurvedic products purchased online contained lead, mercury or arsenic (Saper RB et al., JAMA 2008;300:915–923): improperly prepared metal-based medicines are genuinely hazardous. There are no human safety data for Raupya Bhasma, and none for pregnancy or breastfeeding: avoid in pregnancy. It should only ever be considered under a qualified Ayurvedic practitioner, never self-prescribed or self-dosed, and anyone on prescription medicines should involve their doctor.

FAQs

Is Raupya Bhasma pure silver?

No. Modern analysis shows it consists mainly of crystalline silver: nanoparticle aggregates roughly 170–210 nm, formed during the incineration process, with herb-derived organic groups on the particle surfaces (JAKO 2020). It is structurally distinct both from bulk metallic silver and from the elemental-silver particles in modern colloidal silver products.

Can Raupya Bhasma turn the skin blue?

Chronic excess intake of silver can cause argyria, a permanent grey-blue discolouration of the skin, and this cumulative-toxicity risk is noted across the nano-silver literature (Medwin systematic review). Whether properly dosed Raupya Bhasma carries this risk in practice is unstudied, which is itself a reason it must never be self-dosed or taken long-term without supervision.

Are there human trials of Raupya Bhasma?

No. The available research is limited to material characterisation, in-vitro antimicrobial and human-cell studies, zebrafish-embryo toxicity testing and one animal absorption study in chicks (JAKO 2020; chick study). Reviewers of nano-silver in medicine explicitly call for more toxicity studies before the safety and efficacy of these preparations can be considered established (Medwin review).

Is it the same as colloidal silver?

No. Colloidal silver products are elemental silver particles suspended in liquid. Raupya Bhasma is a calcined Ayurvedic preparation consisting mainly of crystalline silver nanoparticle aggregates with herb-derived surface chemistry from its manufacturing process (JAKO 2020). Different chemistry, different manufacturing tradition: and neither has human-trial evidence for internal medicinal use.

Is Raupya Bhasma safe in pregnancy?

There are no human safety data for Raupya Bhasma in pregnancy or breastfeeding: and no human safety data at all. Animal work shows ingested bhasma-form silver is systemically absorbed and can disturb essential-mineral balance (chick study). In the absence of evidence, avoid in pregnancy unless a qualified practitioner advises otherwise.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Metal-based Ayurvedic preparations must never be self-prescribed or self-dosed. Talk to a qualified Ayurvedic practitioner — and your doctor, if you take prescription medicines — before considering any bhasma, especially if you are pregnant, breastfeeding, or managing a medical condition.